Medical News

RSS

FUJIFILM submits Aspire HD FFDM system 510(k) application to FDA for marketing clearance

FUJIFILM Medical Systems U.S.A., Inc. today announced the submission to the United States Food and Drug Administration of its 510(k) application for marketing clearance of its new Aspire HD Full Field Digital Mammography system.

16 Mar 2011

Cortex enters agreement with Biovail to regain AMPAKINE assets and rights

Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL, a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc., to regain the AMPAKINE® assets and rights related to respiratory depression.

16 Mar 2011

Light files contractual lawsuit against Creation in Tel-Aviv District Court

Light Instruments Ltd., a subsidiary company of Syneron Medical Ltd. and a leading manufacturer of the LiteTouch and Laser-in-Handpiece dental laser breakthrough technologies has filed a lawsuit on March 9, 2011, at the Tel-Aviv District Court, against Creation S.r.l., an Italian company, headed by its CEO, Professor Alfred Resch.

16 Mar 2011

Nukepills.com donates 50,000 potassium iodide tablets to Tokushukai Hospital in Tokyo

Approximately 50,000 potassium iodide tablets have been donated by Nukepills.com to Tokushukai Hospital in Tokyo, Japan for immediate distribution to those affected by Japan's nuclear reactor crisis.

16 Mar 2011

NIFA grants $3.7 million to Temple's CORE for childhood obesity research

Temple's Center for Obesity Research and Education recently received a five year, $3.7 million grant from the USDA's National Institute of Food and Agriculture to fund a project aimed at preventing obesity among low-income pre-schoolers.

16 Mar 2011

Washington Post: Doctors slow to switch to Electronic Health Records

This spring, the federal government will ramp up cash incentives to encourage doctors such as Plotsky to take the step Moore barely thought about in 2004 when George Washington University Medical Faculty Associates introduced its practice-wide electronic system.

16 Mar 2011

Researchers find first-generation x-rays more effective than today's systems

Researchers recently tested first-generation x-ray equipment from 1896 and found that it produced radiation doses and exposure times that were vastly higher than those of today's systems, according a study published online and in the May print edition of Radiology.

16 Mar 2011

RNs step up to meet need for geriatric care

The Sacramento Bee: Gerontology A New Focus For Registered Nurses.

16 Mar 2011

Electric devices can improve aging skin

It may seem as if new developments to combat aging skin are being introduced faster than the speed of light. At the forefront of the research, dermatologists are underpinning these advancements, refining the basic understanding of how the skin ages in order to develop more effective non-invasive cosmetic procedures and products.

16 Mar 2011

NextGen Sciences introduces multiplex protein assay for oncology biomarker discovery

NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its first multiple protein assay, plasmadiscovery41, for oncology biomarker discovery and qualification.

16 Mar 2011

It's the health law's birthday and not everyone is celebrating

The health overhaul's first anniversary — just about a week away — is already being marked on Capitol Hill with a number of hearings and other events related to exploring, complimenting and criticizing the law's implementation.

16 Mar 2011

Shanghai ChemPartner signs outsource research service agreement with Shenogen Pharma

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.

16 Mar 2011

TSO3 revenue decreases to $7.7 million for fiscal year ending December 31, 2010

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, today reported sales for the fiscal year ending December 31, 2010 totalling $939,285 representing the sale of four new generation sterilizers to 3M for training purposes.

16 Mar 2011

Prism Medical receives new UK contract to provide Disability Equipment Services

Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility disadvantaged, today announced that the Company has been awarded a significant new contract to provide Disability Equipment Services for the London Borough of Bexley.

16 Mar 2011

GOP rebellion takes shape around short-term spending bill

Although the measure must be passed in order to avert a government shutdown, some Republicans are frustrated because they say the bill does not go far enough in terms of spending cuts, and because it does not include controversial riders to defund the health law and Planned Parenthood.

16 Mar 2011

Researcher argues against use of Cop1-inhibitory drugs for cancer treatment

Jean-Christophe Marine strongly argues against the use of Cop1-inhibitory drugs. The protein Cop1 has -for a long time - been seen as an attractive drug target for cancer. But Jean-Christophe Marine found out that Cop1 acts as a tumor suppressor, and thus inhibits tumor formation. His new data will have direct implications for the development of cancer drug targets.

16 Mar 2011